OVERVIEW

Astro Rocks: 2022 Astro-Myovant Sciences-Pfizer Alliance New Combination (Relugolix-Radiation) Therapy Challenge is organized by American Society for Radiation Oncology (ASTRO).

Course opens: 05/09/2022
Course expires: 06/01/2025

Description :
Under the ASTRO Advancing-Medicine-Together Scientific Challenges framework, the Myovant Sciences-Pfizer Alliance and ASTRO are partnering to host the 2022 New Combination (Relugolix-Radiation) Therapy Challenge to catalyze new collaborative research opportunities and to facilitate radiation oncology leadership in scientific discovery with the Myovant Sciences-Pfizer Alliance in the space of multimodality combination therapy. In this informational webinar, representatives from the Myovant Sciences-Pfizer Alliance and ASTRO will focus on answering questions from any researchers who are interested in submitting their proposals about:
• The intent of this challenge and potential medical impact
• Relugolix
• The Pfizer ISR Grant System for proposal submission
• Any other general program administration-related topics

Additional details will be posted as soon as information is available.